APA

Detering M., Steels E., Koyyalamudi S. R., Allifranchini E., Bocchietto E. & Vitetta L. (20180727). Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study. : BioFactors (Oxford, England).

Chicago

Detering Matthew, Steels Elizabeth, Koyyalamudi Sundar Rao, Allifranchini Elena, Bocchietto Elena and Vitetta Luis. 20180727. Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study. : BioFactors (Oxford, England).

Harvard

Detering M., Steels E., Koyyalamudi S. R., Allifranchini E., Bocchietto E. and Vitetta L. (20180727). Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study. : BioFactors (Oxford, England).

MLA

Detering Matthew, Steels Elizabeth, Koyyalamudi Sundar Rao, Allifranchini Elena, Bocchietto Elena and Vitetta Luis. Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study. : BioFactors (Oxford, England). 20180727.